Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Spanos

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Investigational New Drugs|March 21, 2022
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinomaSteven F Powell, Miroslaw Mazurczak, Elie G Dib, et al.
Journal for Immunotherapy of Cancer|June 4, 2021
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trialRobert L Ferris, William C Spanos, Rom Leidner, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
ULK1 drives NDP52-mediated selective autophagic degradation of MHC-I to promote immune evasion in HPV-positive head and neck cancerLexi Vu, Nicholas S Giacobbi, Mohamed I Khalil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2020
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB StudySteven F Powell, Kathryn A Gold, Mark M Gitau, et al.
Science Advances|May 10, 2023
Functional neuronal circuits promote disease progression in cancerAnthony C Restaino, Austin Walz, Samuel J Vermeer, et al.
Nature|November 3, 2022
Nociceptor neurons affect cancer immunosurveillanceMohammad Balood, Maryam Ahmadi, Tuany Eichwald, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Investigational New Drugs|March 21, 2022
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinomaSteven F Powell, Miroslaw Mazurczak, Elie G Dib, et al.
Journal for Immunotherapy of Cancer|June 4, 2021
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trialRobert L Ferris, William C Spanos, Rom Leidner, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
ULK1 drives NDP52-mediated selective autophagic degradation of MHC-I to promote immune evasion in HPV-positive head and neck cancerLexi Vu, Nicholas S Giacobbi, Mohamed I Khalil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2020
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB StudySteven F Powell, Kathryn A Gold, Mark M Gitau, et al.
Science Advances|May 10, 2023
Functional neuronal circuits promote disease progression in cancerAnthony C Restaino, Austin Walz, Samuel J Vermeer, et al.
Nature|November 3, 2022
Nociceptor neurons affect cancer immunosurveillanceMohammad Balood, Maryam Ahmadi, Tuany Eichwald, et al.
Pageof 6